Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Licensing Agreement
Sort By
Newest First
1 / 2
1 / 2
Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen
PR-M02-05-02
Feb 21, 2024
Research Collaboration
BigHat Biosciences Completes First Stage of Research Collaboration With Amgen
BigHat Biosciences
PR-M01-22-08
Jan 11, 2022
License Agreement
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION Therapeutics for its Thin Film Freezing Technology in Combination with Niclosamide
TFF Pharmaceuticals
PR-M08-20-NI-26
Aug 14, 2020
Licensing Agreement
ProThera Biologics and Takeda Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins
Takeda
PR-M04-20-NI-034
Apr 24, 2020
Licensing
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
LEO Pharma
PR-M04-20-NI-023
Apr 15, 2020
Licensing
Facilitating Pharma Licensing and Partnering
Erica Sosnowski; Adam Sosnowski
Sosna & Co.
PAP-Q1-20-CL-026
Mar 19, 2020
Legality
Legal Issues in Licensing and M&A
Randy Sunberg
Baker McKenzie
PAP-Q1-20-CL-028
Mar 19, 2020
License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
SeraNovo
PR-M10-19-NI-046
Oct 30, 2019
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
Pfizer
PR-M10-19-NI-020
Oct 11, 2019
Licensing Agreement
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
Innovent
PR-M08-19-NI-076
Aug 27, 2019
Licensing
Harbour BioMed Enters Multi-Year HCAb Technology Licensing Agreement with a Top-Ten Global Pharma for Next Generation Human Antibody Discovery
Harbour BioMed
PR-M05-19-NI-088
May 31, 2019
Licensing Agreement
Transcenta Holding Announces Licensing Agreement with Lilly
Transcenta Holding Limited
PR-M04-19-NI-016
Apr 04, 2019
License Agreement
Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia
Applied Biology
PR-M02-19-NI-030-3040
Feb 13, 2019
Licensing Agreement
Pfizer to License AbbVie’s Humira IP
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-006
Dec 05, 2018
Cell and Gene Therapy
REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector
REGENXBIO
PR-M11-18-NI-028
Nov 08, 2018
Licensing Agreement
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
MEI Pharma, Inc.
PR-M11-18-NI-026
Nov 08, 2018
Licensing Agreement
Grünenthal Acquires Global Rights for Qutenza®
Grünenthal Group
PR-M11-18-NI-020
Nov 06, 2018
Licensing Agreement
REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors
REGENXBIO
PR-M10-18-NI-093
Oct 26, 2018
3D Bioprinting
CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
United Therapeutics Corporation
PR-M10-18-NI-095-3497
Oct 26, 2018
Collaboration and Licensing Agreement
Neovasc Announces Collaboration and Licensing Agreement with Penn Medicine and the Gorman Cardiovascular Research Group
Neovasc
PR-M08-18-NI-053
Aug 14, 2018
